Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626
- 15 July 2010
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 18 (14), 5291-5300
- https://doi.org/10.1016/j.bmc.2010.05.052
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (MH081281, DA023957)
This publication has 54 references indexed in Scilit:
- [3H]4-(dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl) butyl)benzamide: A selective radioligand for dopamine D3receptors. II. Quantitative analysis of dopamine D3and D2receptor density ratio in the caudate-putamenSynapse, 2010
- [3H]4‐(Dimethylamino)‐N‐[4‐(4‐(2‐methoxyphenyl)piperazin‐ 1‐yl)butyl]benzamide, a selective radioligand for dopamine D3 receptors. I. In vitro characterizationSynapse, 2009
- Formation and genotoxicity of a guanine–cytosine intrastrand cross-link lesion in vivoNucleic Acids Research, 2007
- Quantification of oxidative single-base and intrastrand cross-link lesions in unmethylated and CpG-methylated DNA induced by Fenton-type reagentsNucleic Acids Research, 2007
- Analogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SARBioorganic & Medicinal Chemistry Letters, 2007
- Sequence-dependent formation of intrastrand crosslink products from the UVB irradiation of duplex DNA containing a 5-bromo-2′-deoxyuridine or 5-bromo-2′-deoxycytidineNucleic Acids Research, 2006
- Recognition and Incision of Oxidative Intrastrand Cross-Link Lesions by UvrABC NucleaseBiochemistry, 2006
- Independent Generation of the 5-Hydroxy-5,6-dihydrothymidin-6-yl Radical and Its Reactivity in Dinucleoside MonophosphatesJournal of the American Chemical Society, 2004
- Rat liver and kidney contain high densities of σ1 and σ2 receptors: characterization by ligand binding and photoaffinity labelingEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973